Patrick Massoma

发表

Extensive Expression of Collapsin Response Mediator Protein 5 (CRMP5) is a Specific Marker of High-grade Lung Neuroendocrine Carcinoma

J. Honnorat, F. Thivolet, L. Chalabreysse, 2008, The American journal of surgical pathology.

Neuropilin‐2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors

V. Hervieu, J. Scoazec, C. Vercherat, 2019, The Journal of pathology.

mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines

J. Scoazec, C. Vercherat, T. Walter, 2017, Oncotarget.

The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors

V. Hervieu, J. Scoazec, C. Vercherat, 2015, Oncotarget.

Mechanisms of local invasion in enteroendocrine tumors: Identification of novel candidate cytoskeleton-associated proteins in an experimental mouse model by a proteomic approach and validation in human tumors

V. Hervieu, J. Scoazec, Jean-Charles Sanchez, 2015, Molecular and Cellular Endocrinology.

Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors

V. Hervieu, J. Scoazec, C. Vercherat, 2016, Investigational New Drugs.

Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells

V. Hervieu, J. Scoazec, C. Vercherat, 2017, Molecular Cancer Therapeutics.

CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.

F. Ducray, J. Honnorat, R. Khanna, 2015, Cancer research.

The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study

J. Honnorat, H. Kretzschmar, T. Arzberger, 2015, Journal of Neural Transmission.